Background: Left ventricular aneurysm repair (LVAR) prevents congestive heart failure after myocardial infarction (MI). LV dilation after MI is related to postinfarct myocardial remodeling and leads to CHF. Because changes in matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and the physical properties of collagens are involved in myocardial remodeling, the effect of postinfarct LVAR on these factors was tested.
Methods: Rats with surgically induced MI, which did or did not receive postinfarct LVAR, were compared with each other and with controls. TIMP messenger RNA and protein expression, MMP gelatin zymography activity, and collagen fibrosis were measured in heart tissue.
Results: A threefold difference in the infarction area ratio was observed between samples of LVAs and of repaired LVAs. Compared with rats without LVAR, rats with repaired LVAs exhibited a higher percentage fractional shortening and significantly lower LV end-systolic and end-diastolic diameters. These salutary effects on LV diameter after LVAR were accompanied by a reversal of myocardial remodeling activity. After MI, TIMP expression decreased, MMP activity increased, and collagen fibrosis increased. After LVAR, TIMP expression increased, and MMP activity and collagen fibrosis decreased. These markers of remodeling activity changed significantly and approached preinfarct levels after LVAR.
Conclusions: This study demonstrated that postinfarct LVAR prevents further congestive heart failure by attenuating myocardial remodeling in the LV and is thus indicated both to prevent heart failure and to reduce excessive postinfarct myocardial remodeling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.athoracsur.2008.06.043 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assembly of ceria-Nrf2 nanoparticles as macrophage-targeting ROS scavengers protects against myocardial infarction.
Front Pharmacol
January 2025
The Sixth Affiliated Hospital, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target and Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, The Fifth Affiliated Hospital, Guangzhou, China.
Myocardial infarction (MI) is a leading cause of morbidity and mortality worldwide, and mitigating oxidative stress is crucial in managing MI. Nuclear factor erythroid 2-related factor 2 (Nrf2) plays a critical role in combating oxidative stress and facilitating cardiac remodeling post-MI. Here, we engineered Cerium oxide (CeO) nanoparticle-guided assemblies of ceria/Nrf2 nanocomposites to deliver Nrf2 plasmids.
View Article and Find Full Text PDFLeft Ventricular Non-Compaction, Atrial Fibrillation and Mutation in a Young Athlete.
J Clin Med Res
January 2025
Department of Life, Health and Environmental Science, University of L'Aquila, L'Aquila, Italy.
Left ventricular non-compaction (LVNC) is a rare primary cardiomyopathy with genetic etiology, resulting from an abnormality of myocardial development during embryogenesis. It carries an elevated risk of left ventricular dysfunction, thromboembolic events and malignant arrhythmias. We report the case of LVNC associated with paroxysmal atrial fibrillation and ankyrin 2 () mutation at the genetic test.
View Article and Find Full Text PDFNeutrophil-derived apoptotic body membranes-fused exosomes targeting treatment for myocardial infarction.
Regen Biomater
December 2024
Department of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Suzhou Medical College of Soochow University, Soochow University, Suzhou 215006, P. R. China.
Myocardial infarction (MI) poses a substantial threat to human health, prompting extensive research into effective treatment modalities. Preclinical studies have demonstrated the therapeutic potential of mesenchymal stem cell-derived exosomes for cardiac repair. Despite their promise, the inherent limitations of natural exosomes, mainly their restricted targeting capabilities, present formidable barriers to clinical transformation.
View Article and Find Full Text PDFPredictive value of the systemic immune inflammation index in recurrence of atrial fibrillation after radiofrequency catheter ablation.
World J Cardiol
January 2025
Department of Internal Medicine-II, Paracelsus Medical University Salzburg, Salzburg 5020, Austria.
The recurrence of atrial fibrillation (AF) in patients after successful radiofrequency catheter ablation (RFCA) appears to be an unresolved clinical issue and needs to be clearly elucidated. There are many factors associated with AF recurrence, such as duration of AF, male sex, concomitant heart failure, hemodynamic parameters, chronic obstructive pulmonary disease, hypertension, obstructive sleep apnea, hyperthyroidism, smoking and obesity. However, the inflammatory changes are strongly associated with electrical and structural cardiac remodeling, cardiac damage, myocardial fibrotic changes, microvascular dysfunction and altered reparative response.
View Article and Find Full Text PDFA novel uORF regulates folliculin to promote cell growth and lysosomal biogenesis during cardiac stress.
Sci Rep
January 2025
Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany.
Pathological cardiac remodeling is a maladaptive response that leads to changes in the size, structure, and function of the heart. These changes occur due to an acute or chronic stress on the heart and involve a complex interplay of hemodynamic, neurohormonal and molecular factors. As a critical regulator of cell growth, protein synthesis and autophagy mechanistic target of rapamycin complex 1 (mTORC1) is an important mediator of pathological cardiac remodeling.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!